About the Company
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers (i.e. home health, hospice, skilled nursing facilities, life plan communities, senior living centers, and private duty). Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
5138
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on RESMED INC
Resmed Inc Announces Proposed Sale of Securities
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has provided an announcement. Resmed Inc has filed a notice ...
ResMed Updates Dividend Exchange Rate for ASX CDI Holders
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) just unveiled an announcement. ResMed Inc has announced an ...
ResMed Inc. stock falls Thursday, underperforms market
Shares of ResMed Inc. RMD slid 1.03% to $284.72 Thursday, on what proved to be an all-around mixed trading session for the ...
Resmed, Inc.: Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in th ...
ResMed Inc. stock rises Wednesday, outperforms market
Shares of ResMed Inc. RMD advanced 1.76% to $288.28 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.32% to 6,466.58 ...
Wilsons downgrades Resmed Inc CHESS Depositary Interests on a ratio of ...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has an analyst consensus of Strong Buy, with a price target consensus of A$43.76, implying an 11.95% upside from current levels.
Agree To Purchase ResMed At $145, Earn 6.1% Using Options
So unless ResMed Inc. sees its shares fall 34% and the contract is exercised (resulting in a cost basis of $136.20 per share before broker commissions, subtracting the $8.80 from $145), the only ...
ResMed Inc. Earnings: Keeping the Profitability Streak Alive
ResMed Inc. reported net income above Wall Street’s expectations for the second quarter. ResMed is a developer, manufacturer and distributor of medical equipment for treating, diagnosing and ...
Downgrading ResMed Inc. Because It's Doing Well (NYSE:RMD)
Several factors led us to reassess our stock rating of ResMed Inc. (RMD) from buy to watchful hold. The share price is currently ~10% below its 52-week high of $260.49 and its valuation grade is low.
Similar Companies
Loading the latest forecasts...